The Most Interesting Questions And Opportunities In Cell Therapy Development

Cell therapy is advancing rapidly, but major questions remain. Experts are exploring how to identify novel antigens for targeted therapies and overcome challenges like antigen escape in tumor cells. Understanding what regulates antigen expression could unlock new strategies to enhance treatment efficacy. Beyond biology, the commercial space faces hurdles in workflow standardization—automation, cost reduction, and quality control are critical to scaling cell therapy. Variability in assays, reagents, and instrumentation adds complexity, making consistent, comparable data a top priority. Researchers are also investigating differences in response correlates between solid and liquid tumors, as well as new applications in flow cytometry and cell analysis. These insights highlight the need for collaboration and innovation to drive progress in the next decade.

Listen to the full discussion to learn where the biggest opportunities lie in cell therapy development.